Why your booze-free drink costs just as much as the alcoholic kind | CBC Radio
www.cbc.ca/radio/costofliving/booze-free-costly-9.6969478?cmp=rssThe non-alcoholic beverage market in Canada is growing, but prices remain high. This is due to the complex and costly production process, similar to alcoholic beverages, and the need to maintain a premium price point to ensure perceived quality. As the market matures, prices may decrease slightly, but non-alcoholic drinks are likely to remain premium products.
Apple @ Work: How Apple Vision Pro is helping redefine accessibility through non-invasive brain-computer interfaces - 9to5Mac
9to5mac.com/2025/11/08/how-apple-vision-pro-is-helping-redefine-accessibility-through-non-invasive-brain-computer-interfacesCognixion is using Apple Vision Pro in a clinical study to explore how people with conditions like ALS and spinal cord injuries can communicate using brain signals, eye tracking, and AI. The study, which runs through April 2026, leverages Vision Pro’s high-resolution video passthrough and accessibility features like Eye Tracking and AssistiveTouch. This collaboration highlights how Apple’s accessibility framework, while not designed for medical use, is enabling significant advancements in healthcare technology.
Long-term use of melatonin supplements to support sleep may have negative health effects
newsroom.heart.org/news/long-term-use-of-melatonin-supplements-to-support-sleep-may-have-negative-health-effectsA study of over 130,000 adults with insomnia found that long-term melatonin use (over a year) was associated with a higher risk of heart failure, hospitalization, and death. The study, presented at the American Heart Association’s Scientific Sessions 2025, raises concerns about the safety of melatonin, a widely used sleep aid. Researchers emphasize the need for further research to assess melatonin’s cardiovascular safety.
A study of 130,828 adults with insomnia found a potential link between melatonin use and heart failure. The study, using data from the TriNetX network, compared 65,414 participants prescribed melatonin for at least a year to a control group. While the study raises safety concerns, it cannot prove a direct cause-and-effect relationship, highlighting the need for further research.
Contact 1-800-AHA-USA1 for public inquiries.